Ionis Pharmaceuticals (IONS) Other Non-Current Liabilities (2010 - 2026)

Ionis Pharmaceuticals' Other Non-Current Liabilities history runs 13 years deep, the most recent figure standing at $28.3 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 49.21% year-over-year to $28.3 million; the TTM figure through Mar 2026 stood at $28.3 million (down 49.21% YoY), while the FY2025 annual figure was $28.1 million, down 45.85% from the prior year.
• Other Non-Current Liabilities was $28.3 million for Q1 2026 at Ionis Pharmaceuticals, up from $28.1 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $525.1 million in Q1 2024 to a low of $28.1 million in Q4 2025.
• Historically, Other Non-Current Liabilities has averaged $223.2 million across 4 years, with a median of $55.7 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities sank 91.86% in 2024, then soared 41.42% in 2025.
• A 4-year view of Other Non-Current Liabilities shows it stood at $513.7 million in 2023, then slumped by 89.89% to $51.9 million in 2024, then tumbled by 45.85% to $28.1 million in 2025, then climbed by 0.55% to $28.3 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $28.3 million (Q1 2026), $28.1 million (Q4 2025), and $28.8 million (Q3 2025), per Business Quant data.